Research Topics
| Andrew BoulleSummaryAffiliation: University of Alabama at Birmingham Country: USA Publications
| Collaborators
|
Detail Information
Publications
Determinants of stillbirth in ZambiaElizabeth M Stringer
University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA
Obstet Gynecol 117:1151-9. 2011..The objective of this study was to estimate the rates and determinants of stillbirth in an urban African obstetric population...
Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birthElizabeth Stringer
Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama, USA
S Afr Med J 100:58-64. 2010..To determine whether treatment of trichomoniasis increases the risk of prematurity...- Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus InitiativeElizabeth M Stringer
Center for Infectious Disease Research in Zambia, Lusaka, Zambia
AIDS 23:S69-77. 2009..HIV-infected women need access to safe and effective contraception. Recent animal and human data suggest that hormonal contraception may accelerate HIV disease progression... - HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trialElizabeth M Stringer
Centre for Infectious Disease Research, Lusaka, Zambia
AIDS 23:1377-82. 2009..We hypothesized that women using depomedroxyprogesterone acetate (DMPA) contraception would have faster HIV disease progression than women using oral contraceptive pills (OCPs) and nonhormonal methods... - Declining HIV prevalence among young pregnant women in Lusaka, ZambiaElizabeth M Stringer
Department of Obstetrics and Gynecology, University of Alabama, Birmingham, AL, United States of America
Bull World Health Organ 86:697-702. 2008..Recent reports suggest a possible decline in HIV sero-incidence in Zambia and some neighbouring countries. This study aimed to examine trends in HIV seroprevalence among pregnant and parturient women between 2002 and 2006... - Hormonal contraception and HIV disease progressionElizabeth Stringer
Department of Obstetrics and Gynecology, Division of International Women s Health, University of Alabama at Birmingham, USA
Clin Infect Dis 47:945-51. 2008..Additional work is needed in this area to elucidate the possible relationship between hormonal methods for birth control and progression to acquired immunodeficiency syndrome in HIV-infected women... - Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countriesElizabeth M Stringer
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
Bull World Health Organ 86:57-62. 2008..Finally, we propose a novel community survey-based approach that could be implemented widely throughout the developing world with minor modifications to ongoing Demographic and Health Surveys... - A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virusElizabeth M Stringer
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
Am J Obstet Gynecol 197:144.e1-8. 2007..The purpose of this study was to determine whether the intrauterine contraceptive device (IUD) is effective and safe among women who are infected with the human immunodeficiency virus (HIV)... - Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric populationElizabeth M Stringer
Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
J Acquir Immune Defic Syndr 35:60-6. 2004..Before significant inroads can be made in decreasing the incidence of HIV infection among pregnant women, population-based strategies that involve men must be implemented... - Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countriesElizabeth M Stringer
Centre for Infectious Disease Research in Zambia, Plot 1275 Lubutu Rd, PO Box 34681, Lusaka, Zambia
JAMA 304:293-302. 2010..Few studies have objectively evaluated the coverage of services to prevent transmission of human immunodeficiency virus (HIV) from mother to child... - Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countriesMartin W G Brinkhof
Institute of Social and Preventive Medicine, Bern, Switzerland
Bull World Health Organ 86:559-67. 2008..To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resource-limited settings... 
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesPaula Braitstein
Lancet 367:817-24. 2006..Timely diagnosis and assessment of treatment eligibility, coupled with free provision of HAART, might reduce this excess mortality...- Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countriesMartin W G Brinkhof
Institute of Social and Preventive Medicine ISPM, University of Berne, Finkenhubelweg 11, CH 3012 Bern, Switzerland
Clin Infect Dis 45:1518-21. 2007..48 (95% confidence interval, 0.36-0.64) in low-income countries and 0.36 (95% confidence interval, 0.26-0.50) in high-income countries. A low CD4 cell count at the start of therapy was the most important risk factor in both settings... - Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South AfricaDavid Coetzee
Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Bull World Health Organ 83:489-94. 2005.... - Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapyAndrew Boulle
School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
JAMA 300:530-9. 2008..Rifampicin-based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well described... - Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohortsFrancois Dabis
INSERM U 593, ISPED, Universite Victor Segalen, Bordeaux Cedex, France
Int J Epidemiol 34:979-86. 2005 - Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort studyMary Ann Davies
Red Cross War Memorial Children s Hospital and the School of Child and Adolescent Health, University of Cape Town, Cape Town, The Republic of South Africa
BMC Pediatr 8:34. 2008..This study describes the utility of different measures of adherence in detecting lapses in infants and young children in Cape Town, South Africa... - Antiretroviral therapy in resource-poor settings: scaling up inequalities?Matthias Egger
Int J Epidemiol 34:509-12. 2005 - Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South AfricaDavid Coetzee
Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa
AIDS 18:887-95. 2004..With responsible implementation, ART is a key component of a comprehensive response to the epidemic in those communities most affected by HIV... - The ART of rationing--the need for a new approach to rationing health interventionsChristopher Kenyon
Department of Medicine, Somerset Hospital and University of Cape Town
S Afr Med J 93:56-60. 2003..The current global context that precipitates and exacerbates the parallel contouring of disease burden and poverty should be constantly challenged... - Commentary: Factors affecting HIV/AIDS-related stigma and discrimination by medical professionalsHarriet Deacon
History Department, University of Cape Town, Private Bag, Rondebosch 7700, South Africa
Int J Epidemiol 36:185-6. 2007 - When best practice is bad medicine: a new approach to rationing tertiary health services in South AfricaChris Kenyon
Division of Infectious Diseases and HIV Medicine at Groote Schuur Hospital, Cape Town
S Afr Med J 98:350, 352, 354 passim. 2008 - Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedOlivia Keiser
Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
PLoS Med 5:e148. 2008..We compared virologic response, changes to first-line regimens, and mortality in HIV-infected patients starting HAART in South Africa and Switzerland... - CD4 T-cell responses to combination antiretroviral therapyGary Maartens
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
Lancet 370:366-8. 2007 - Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohortAndrew Boulle
Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Antivir Ther 12:753-60. 2007..The patterns and reasons for antiretroviral therapy (ART) drug substitutions are poorly described in resource-limited settings... - Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaborationElise Arrive
Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, Bordeaux, France
Int J Epidemiol 37:474-80. 2008 - Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosisKaren Cohen
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa
J Antimicrob Chemother 61:389-93. 2008..We describe the steady-state pharmacokinetics of nevirapine during and after antitubercular therapy in South African patients... - Effectiveness of antiretroviral treatment in a South African program: a cohort studyLara R Fairall
Knowledge Translation Unit, University of Cape Town Lung Institute, University of Cape Town, Cape Town, South Africa
Arch Intern Med 168:86-93. 2008.... - Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationPaula Braitstein
Department of Medicine, Indiana University, Indianapolis, Indiana, USA
J Womens Health (Larchmt) 17:47-55. 2008.... - Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin AmericaOlivia Keiser
Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
Trop Med Int Health 13:870-9. 2008..To describe temporal trends in baseline clinical characteristics, initial treatment regimens and monitoring of patients starting antiretroviral therapy (ART) in resource-limited settings... - Population effect of scaling up ART in resource-poor settingsMatthias Egger
International epidemiological Databases to Evaluate AIDS (IeDEA, Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Lancet 371:1558-9. 2008 - Exploring the costs of a limited public sector antiretroviral treatment programme in South AfricaAndrew Boulle
School of Public Health and Primary Health Care, University of Cape Town
S Afr Med J 92:811-7. 2002..Such a programme is affordable within current resource constraints. The consideration of antiretroviral treatment calls for a unique public health approach to the rationing of health services in the public sector...